Sudhakar Voruganti, Ph.D. - Publications
Affiliations: | 2013 | Biochemistry & Molecular Biology | Oklahoma State University, Stillwater, OK, United States |
Area:
Biochemistry, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2018 | Voruganti S, Kline JT, Balch MJ, Rogers J, Matts RL, Hartson SD. Proteomic Profiling of Hsp90 Inhibitors. Methods in Molecular Biology (Clifton, N.J.). 1709: 139-162. PMID 29177657 DOI: 10.1007/978-1-4939-7477-1_11 | 0.56 | |||
2013 | Voruganti S, Lacroix JC, Rogers CN, Rogers J, Matts RL, Hartson SD. The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors. Journal of Proteome Research. 12: 3697-706. PMID 23763277 DOI: 10.1021/Pr400321X | 0.584 | |||
2013 | Voruganti S, Lacroix JC, Rogers CN, Rogers J, Matts RL, Hartson SD. The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors Journal of Proteome Research. 12: 3697-3706. DOI: 10.1021/pr400321x | 0.578 | |||
2011 | Matts RL, Dixit A, Peterson LB, Sun L, Voruganti S, Kalyanaraman P, Hartson SD, Verkhivker GM, Blagg BS. Elucidation of the Hsp90 C-terminal inhibitor binding site. Acs Chemical Biology. 6: 800-7. PMID 21548602 DOI: 10.1021/Cb200052X | 0.516 | |||
Show low-probability matches. |